Pure and Organic CBD & and Hemp Products

Effective medicine provided by mother nature

  • Powerful relaxant

  • Strong painkiller

  • Stress reduction
  • Energy booster

Why CBD?

More and more renowned scientists worldwide publish their researches on the favorable impact of CBD on the human body. Not only does this natural compound deal with physical symptoms, but also it helps with emotional disorders. Distinctly positive results with no side effects make CBD products nothing but a phenomenal success.

This organic product helps cope with:

  • Tight muscles
  • Joint pain
  • Stress and anxiety
  • Depression
  • Sleep disorder

Range of Products

We have created a range of products so you can pick the most convenient ones depending on your needs and likes.

CBD Capsules Morning/Day/Night:

CBD Capsules

These capsules increase the energy level as you fight stress and sleep disorder. Only 1-2 capsules every day with your supplements will help you address fatigue and anxiety and improve your overall state of health.

Order Now

CBD Tincture

CBD Tincture

No more muscle tension, joints inflammation and backache with this easy-to-use dropper. Combined with coconut oil, CBD Tincture purifies the body and relieves pain. And the bottle is of such a convenient size that you can always take it with you.

Order Now

Pure CBD Freeze

Pure CBD Freeze

Even the most excruciating pain can be dealt with the help of this effective natural CBD-freeze. Once applied on the skin, this product will localize the pain without ever getting into the bloodstream.

Order Now

Pure CBD Lotion

Pure CBD Lotion

This lotion offers you multiple advantages. First, it moisturizes the skin to make elastic. And second, it takes care of the inflammation and pain. Coconut oil and Shia butter is extremely beneficial for the health and beauty of your skin.

Order Now

2500mg 30ml Full Spectrum CBD Oil Tincture

syndrome Double-blind Dravet trial in

kvaygon
01.03.2019

Content:

  • syndrome Double-blind Dravet trial in
  • Dravet Syndrome Clinical Trials
  • Associated Data
  • In this double-blind, placebo-controlled trial, we randomly assigned children and young adults with the Dravet syndrome and drug-resistant. Long-term cannabidiol treatment in patients with Dravet syndrome: An associated with Dravet syndrome (DS) in a randomized, double-blind, enroll in a long-term open-label extension trial, GWPCARE5 (NCT). We studied cannabidiol for the treatment of drug-resistant seizures in the Dravet syndrome. METHODS: In this double-blind, placebo-controlled trial, we.

    syndrome Double-blind Dravet trial in

    The Caregiver Global Impression of Change, a seven-point scale, was used as a secondary end-point measure. Adverse events led with withdrawal from the trial of eight patients in the CBD group and one in the placebo group.

    Other adverse events that occurred more frequently in the CBD group than the placebo group included diarrhea, vomiting, fatigue, pyrexia, and liver-function test result abnormalities. The importance of this study is that, unlike most other antiseizure medication trials, it assesses a treatment in a specific epilepsy syndrome with a known genetic basis.

    CBD resulted in a significant decrease of convulsive seizures and seizures of all types in Dravet syndrome, a pharmacoresistant epilepsy known to be associated with high mortality rates. The role of cannabinoid receptors in modulating seizure activity has been studied. For example, mutant mice that lack expression of the cannabinoid receptor type 1 CB1 in principal forebrain neurons but not in adjacent inhibitory interneurons exhibited excessive seizures in the kainic acid model 4.

    Unlike the wild type, mutant mice failed to mount increased levels of anandamide in the hippocampus. Another study demonstrated that cannabinoids abolished seizures in rats using the pilocarpine model, whereas CB1 antagonism resulted in seizure exacerbation and status epilepticus 5.

    Why these mechanisms appear to improve seizures in Dravet syndrome, and whether the results benefit other epilepsies remain to be established. National Center for Biotechnology Information , U. Journal List Epilepsy Curr v.

    Mohamad Koubeissi , MD. Author information Copyright and License information Disclaimer. Authors have a Conflict of Interest disclosure which is posted under the Supplemental Materials link. Supplementary Material Click here for additional data file. A listing of Dravet Syndrome medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

    This study addresses the changes in the axonal excitability parameters. It will compare these changes in patients with early infantile epileptic encephalopathy with HCN1 channel mutation and in control patients, with and without epilepsy.

    This study is a 1: A day screening period prior to randomization to establish baseline parameters will precede the treatment period, which will consist of a two-week titration period followed by a week maintenance period. This is a multicenter, double-blind, parallel-group, placebo-controlled, study to assess the efficacy, safety, and pharmacokinetics of ZX when used as adjunctive therapy in pediatric and young adult subjects with Dravet syndrome. Interactions between cannabidiol and commonly used antiepileptic drugs.

    Cutter , Yuliang Liu , Jerzy P. Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: Stephen Marc Stout , Nina M. Jacqueline S Gofshteyn , Angus A. Cannabinoids in treatment-resistant epilepsy: A review Brooke K. O'Connell , David S.

    Dravet Syndrome Clinical Trials

    Dravet Syndrome Clinical Research Trial Listings in Rare Diseases and Disorders This study is a randomized, double-blind, week comparison of two. Full Title: Population pharmacokinetic study in Dravet's syndrome patients treated Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of Two. ZX (Fenfluramine HCl Oral Solution) in Dravet Syndrome: Results of a Phase 3,. Randomized, Double-Blind, Placebo-Controlled Trial. Lieven Lagae1.

    Associated Data



    Comments

    th1th

    Dravet Syndrome Clinical Research Trial Listings in Rare Diseases and Disorders This study is a randomized, double-blind, week comparison of two.

    moraitis

    Full Title: Population pharmacokinetic study in Dravet's syndrome patients treated Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of Two.

    avalonmd

    ZX (Fenfluramine HCl Oral Solution) in Dravet Syndrome: Results of a Phase 3,. Randomized, Double-Blind, Placebo-Controlled Trial. Lieven Lagae1.

    sareptarobot

    Official Title: A Double Blind, Placebo Controlled Two-part Study to Investigate the . Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.

    breenno

    Clinical trial results of medicinal marijuana for treatment in Dravet syndrome. Research findings have just been published from the first randomised, double- blind.

    resss4

    GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol ( GWPP) in Children and Young Adults With Dravet Syndrome.

    Add Comment